DE3177306D1 - Verfahren und Verbindungen zur Herstellung von H-ARG-X-Z-Y-TYR-R. - Google Patents

Verfahren und Verbindungen zur Herstellung von H-ARG-X-Z-Y-TYR-R.

Info

Publication number
DE3177306D1
DE3177306D1 DE84201633T DE3177306T DE3177306D1 DE 3177306 D1 DE3177306 D1 DE 3177306D1 DE 84201633 T DE84201633 T DE 84201633T DE 3177306 T DE3177306 T DE 3177306T DE 3177306 D1 DE3177306 D1 DE 3177306D1
Authority
DE
Germany
Prior art keywords
tyr
arg
methods
compounds
making
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE84201633T
Other languages
English (en)
Other versions
DE3177306T2 (de
Inventor
George Heavner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ortho Pharmaceutical Corp
Original Assignee
Ortho Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22576099&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3177306(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ortho Pharmaceutical Corp filed Critical Ortho Pharmaceutical Corp
Application granted granted Critical
Publication of DE3177306D1 publication Critical patent/DE3177306D1/de
Publication of DE3177306T2 publication Critical patent/DE3177306T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0819—Tripeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/66—Thymopoietins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • C07K5/06095—Arg-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DE3177306T 1980-06-17 1981-06-16 Verfahren und Verbindungen zur Herstellung von H-ARG-X-Z-Y-TYR-R. Expired - Fee Related DE3177306T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/160,241 US4298523A (en) 1980-06-17 1980-06-17 Methods and compositions for preparation of H-ARG-X-Z-Y-TYR-R

Publications (2)

Publication Number Publication Date
DE3177306D1 true DE3177306D1 (de) 1994-02-10
DE3177306T2 DE3177306T2 (de) 1994-06-30

Family

ID=22576099

Family Applications (2)

Application Number Title Priority Date Filing Date
DE8181302685T Expired DE3175701D1 (en) 1980-06-17 1981-06-16 Methods and compositions for preparation of h-arg-x-z-y-tyr-r
DE3177306T Expired - Fee Related DE3177306T2 (de) 1980-06-17 1981-06-16 Verfahren und Verbindungen zur Herstellung von H-ARG-X-Z-Y-TYR-R.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE8181302685T Expired DE3175701D1 (en) 1980-06-17 1981-06-16 Methods and compositions for preparation of h-arg-x-z-y-tyr-r

Country Status (19)

Country Link
US (1) US4298523A (de)
EP (3) EP0565148A2 (de)
JP (3) JPS5728036A (de)
AT (2) ATE24183T1 (de)
AU (3) AU562807B2 (de)
CA (6) CA1188297A (de)
DE (2) DE3175701D1 (de)
DK (3) DK151968C (de)
ES (3) ES503012A0 (de)
FI (1) FI79329C (de)
GR (1) GR74546B (de)
IE (3) IE62213B1 (de)
IL (7) IL72393A (de)
NO (3) NO161744C (de)
NZ (1) NZ197294A (de)
PH (2) PH16501A (de)
PT (1) PT73201B (de)
YU (1) YU45852B (de)
ZA (1) ZA814061B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4369137A (en) * 1980-06-17 1983-01-18 Ortho Pharmaceutical Corporation N-Protected pentapeptides useful as intermediates in the preparation of thymopoietin pentapeptide
US4499079A (en) * 1982-11-18 1985-02-12 E. R. Squibb & Sons, Inc. Carboxy and substituted carboxy alkanoyl and cycloalkanoyl peptides
DE3401545A1 (de) * 1983-08-03 1985-02-14 Hoechst Ag, 6230 Frankfurt Neue peptide mit immunstimulierender wirkung, verfahren zu deren herstellung und deren verwendung
US4505853A (en) * 1983-11-18 1985-03-19 Ortho Pharmaceutical Corporation Enzyme-resistant immunomodulatory peptides
AU602483B2 (en) * 1985-01-18 1990-10-18 Immunetech Pharmaceuticals Immunoregulatory peptides
US4749690A (en) * 1986-01-27 1988-06-07 Ortho Pharmaceutical Corporation Treatment of allergy with thymopentin
US4732970A (en) * 1986-06-13 1988-03-22 American Cyanamid Company Antitumor amino acid and peptide derivatives of 1,4-bis(aminoalkyl and hydroxy-aminoalkyl)amino)-5,8-dihydroxyanthraquinones
US5200506A (en) * 1987-03-19 1993-04-06 Eniricerche S.P.A. Process for preparing new thymopentin retro-inverso analogs and fragments thereof and the intermediates obtained therein
HU199878B (en) * 1987-06-19 1990-03-28 Berlin Chemie Veb Process for producing acylated splenopentynes and pharmaceutical compositions comprising such compounds as active ingredient
US5656601A (en) * 1987-06-19 1997-08-12 Berlin-Chemie Ag Acylated splenopentins, methods for their synthesis and their use
FR2622587B1 (fr) * 1987-10-30 1990-12-21 Inst Vaisseaux Sang Peptide lysyl-arginyl-aspartyl-serine et ses applications en tant que medicament, notamment antithrombotique
NZ229004A (en) * 1988-05-19 1993-09-27 Immunobiology Res Inst Inc Tetrapeptides having t cell helper acitivity
JPH01264767A (ja) * 1988-11-17 1989-10-23 G N Tool Kk 砥石自動交換ｃｎｃ工具研削盤
CN101168560B (zh) * 2006-10-23 2012-09-05 江苏正大天晴药业股份有限公司 N-取代肽酰胺，其药物组合物与用途
EP2376101B1 (de) 2008-12-29 2015-12-02 Trevena, Inc. Beta-arrestin-effektoren und zusammensetzungen und anwendungsverfahren dafür
JP2017506235A (ja) 2014-02-07 2017-03-02 トレベナ・インコーポレイテッドＴｒｅｖｅｎａ， Ｉｎｃ． ベータ−アレスチンエフェクターの結晶性および非晶質形態
AU2015264367A1 (en) 2014-05-19 2016-12-15 Trevena, Inc. Synthesis of Beta-Arrestin Effectors

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3317559A (en) * 1963-08-23 1967-05-02 American Cyanamid Co alpha-amino acid esters of n-hydroxysuccinimide and preparation and use in peptide synthesis
DE1593830A1 (de) * 1967-05-24 1971-03-11 Akad Wissenschaften Ddr Verfahren zur Herstellung von Peptiden
US3560503A (en) * 1968-09-18 1971-02-02 Council Scient Ind Res Di-lower alkyl-substituted octahydropyrazinopyrimidinones
JPS4826010B1 (de) * 1969-11-11 1973-08-03
US3997516A (en) * 1974-07-04 1976-12-14 Takeda Chemical Industries, Ltd. Method for protecting guanidino group and restoring the same
DE2544348C3 (de) * 1975-10-03 1979-12-13 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen L-Leucin-13-Motilin, Verfahren zu dessen Herstellung und dasselbe enthaltendes Mittel
US4190646A (en) * 1975-11-11 1980-02-26 Sloan-Kettering Institute For Cancer Research Polypeptide compositions and methods
SE446867B (sv) * 1977-11-15 1986-10-13 Sloan Kettering Inst Cancer Sett att framstella en polypeptid med formaga att inducera differentiering av t-lymfocyter men inte av komplementreceptor (cr?72+) b-lymfocyter
US4215112A (en) * 1979-03-14 1980-07-29 Ortho Pharmaceutical Corporation Tripeptides and methods
US4215111A (en) * 1979-03-14 1980-07-29 Ortho Pharmaceutical Corporation Peptides having ubiquitin-like activity
CA1156220A (en) * 1979-04-26 1983-11-01 George Heavner Method and composition for preparation of h-sar-lys-sar-gln-nh.sub.2
DE2938420A1 (de) * 1979-09-22 1981-04-09 Hoechst Ag, 6000 Frankfurt Neue peptide und verfahren zu ihrer herstellung
US4309340A (en) * 1980-03-31 1982-01-05 American Home Products Corporation Polypeptide compositions

Also Published As

Publication number Publication date
DK415485D0 (da) 1985-09-12
ES8303298A1 (es) 1983-02-01
AU4566785A (en) 1985-11-07
NZ197294A (en) 1984-12-14
CA1315041C (en) 1993-03-23
AU4566885A (en) 1985-11-07
PH21622A (en) 1987-12-11
NO166532C (no) 1991-08-07
IL72393A (en) 1985-06-30
IE811336L (en) 1981-12-17
PT73201A (en) 1981-07-01
US4298523A (en) 1981-11-03
EP0042291A2 (de) 1981-12-23
CA1188297A (en) 1985-06-04
EP0144103A2 (de) 1985-06-12
YU45852B (sh) 1992-09-07
NO166532B (no) 1991-04-29
EP0144103A3 (en) 1988-08-10
NO900294L (no) 1981-12-18
GR74546B (de) 1984-06-29
AU4566685A (en) 1985-11-07
DK154653C (da) 1989-05-01
YU152881A (en) 1984-02-29
ES8304541A1 (es) 1983-03-01
EP0565148A3 (de) 1994-02-09
FI811883L (fi) 1981-12-18
NO164245B (no) 1990-06-05
AU562807B2 (en) 1987-06-18
DK154437C (da) 1989-04-10
JPH01308297A (ja) 1989-12-12
ES8207513A1 (es) 1982-10-01
IE62614B1 (en) 1995-02-22
JPH01308298A (ja) 1989-12-12
NO161744B (no) 1989-06-12
IE62213B1 (en) 1995-01-11
IL63108A (en) 1985-06-30
IL72392A0 (en) 1984-11-30
ATE24183T1 (de) 1986-12-15
IL72392A (en) 1985-06-30
ES512721A0 (es) 1983-02-01
NO812035L (no) 1981-12-18
DK151968B (da) 1988-01-18
DE3175701D1 (en) 1987-01-22
DK415485A (da) 1985-09-12
PH16501A (en) 1983-11-04
ES512722A0 (es) 1983-03-01
DK227787A (da) 1987-05-04
IL72394A (en) 1985-06-30
CA1315042C (en) 1993-03-23
CA1282550C (en) 1991-04-02
DK151968C (da) 1988-09-19
NO164245C (no) 1990-09-12
NO161744C (no) 1989-09-20
DK263781A (da) 1981-12-18
NO885646L (no) 1981-12-18
FI79329B (fi) 1989-08-31
EP0042291B1 (de) 1986-12-10
IE940518L (en) 1981-12-17
JPS5728036A (en) 1982-02-15
JPH0357118B2 (de) 1991-08-30
DE3177306T2 (de) 1994-06-30
EP0042291A3 (en) 1982-03-31
ES503012A0 (es) 1982-10-01
FI79329C (fi) 1989-12-11
IE881720L (en) 1981-12-17
EP0144103B1 (de) 1993-12-29
IL63108A0 (en) 1981-09-13
CA1285099C (en) 1991-06-18
DK154437B (da) 1988-11-14
ZA814061B (en) 1983-01-26
NO900294D0 (no) 1990-01-22
DK227787D0 (da) 1987-05-04
CA1315040C (en) 1993-03-23
EP0565148A2 (de) 1993-10-13
PT73201B (en) 1983-04-26
AU562808B2 (en) 1987-06-18
JPH0354957B2 (de) 1991-08-21
AU563303B2 (en) 1987-07-02
JPH0355480B2 (de) 1991-08-23
ATE99327T1 (de) 1994-01-15
IL72393A0 (en) 1984-11-30
NO885646D0 (no) 1988-12-20
IL72394A0 (en) 1984-11-30
DK154653B (da) 1988-12-05

Similar Documents

Publication Publication Date Title
DE3177306D1 (de) Verfahren und Verbindungen zur Herstellung von H-ARG-X-Z-Y-TYR-R.

Legal Events

Date Code Title Description
8363 Opposition against the patent
8365 Fully valid after opposition proceedings
8339 Ceased/non-payment of the annual fee